CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 34 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,834,000 | -19.4% | 4,516,000 | 0.0% | 0.06% | -29.5% |
| Q1 2019 | $3,515,000 | +4.1% | 4,516,000 | -5.8% | 0.08% | -4.9% |
| Q4 2018 | $3,378,000 | -20.7% | 4,796,000 | -12.0% | 0.08% | -6.8% |
| Q3 2018 | $4,259,000 | -79.9% | 5,450,000 | -76.3% | 0.09% | -80.3% |
| Q2 2018 | $21,215,000 | – | 22,989,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 48,566,000 | $34,360,000 | 1.32% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 29,000,000 | $20,108,000,000 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 51,910,000 | $36,077,000 | 0.22% |
| Antara Capital LP | 37,028,000 | $353,000 | 0.07% |
| CSS LLC/IL | 1,000,000 | $712,000 | 0.03% |
| ARISTEIA CAPITAL, L.L.C. | 1,463,000 | $1,037,000 | 0.03% |
| Allianz Asset Management GmbH | 29,945,000 | $21,044,000 | 0.02% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $5,315,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 23,550,000 | $16,725,000 | 0.02% |
| AMERIPRISE FINANCIAL INC | 42,000,000 | $29,131,000 | 0.01% |